Literature DB >> 11173630

Risk Factors for AIDS Associated Kaposi's Sarcoma. An European Multicentre Case Control Study.

Jordi Casabona1, Gemma Gambús, Marti Vall, Anna Rodés.   

Abstract

EURO-SHAKS, European study on HIV associated Kaposi's sarcoma, is a BIOMED 1 project financed by the European Union (DG XII). The Spanish side of the project has been financed by FISS (Fondo de Investigaciones Sanitarias). The aims of this study are to identify possible genetic, behavioural, biological and environmental risk factors for HIV associated Kaposi's sarcoma through a multicentre case-control study. An extensive personal questionnaire, a clinical data form and blood sample is required from all participants. In addition, a cutaneous biopsy is request from KS patients. The presence of several European groups in this project implies a large and diverse sample size and will allow to correlate the behaviour, clinical and biological data in different geographical areas, and therefore study the possible transmission routes as well as the natural history of the putative causal agent of KS. One of the main objectives of EURO-SHAKS is to create a European Bank of AIDS biological samples for possible future investigations.

Entities:  

Year:  1997        PMID: 11173630     DOI: 10.1007/bf02893358

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  10 in total

1.  Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS.

Authors:  V Beral; D Bull; S Darby; I Weller; C Carne; M Beecham; H Jaffe
Journal:  Lancet       Date:  1992-03-14       Impact factor: 79.321

2.  Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.

Authors:  G R Simpson; T F Schulz; D Whitby; P M Cook; C Boshoff; L Rainbow; M R Howard; S J Gao; R A Bohenzky; P Simmonds; C Lee; A de Ruiter; A Hatzakis; R S Tedder; I V Weller; R A Weiss; P S Moore
Journal:  Lancet       Date:  1996-10-26       Impact factor: 79.321

3.  Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma.

Authors:  C Boshoff; D Whitby; T Hatziioannou; C Fisher; J van der Walt; A Hatzakis; R Weiss; T Schulz
Journal:  Lancet       Date:  1995-04-22       Impact factor: 79.321

4.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.

Authors:  S J Gao; L Kingsley; M Li; W Zheng; C Parravicini; J Ziegler; R Newton; C R Rinaldo; A Saah; J Phair; R Detels; Y Chang; P S Moore
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

5.  The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission.

Authors:  D H Kedes; E Operskalski; M Busch; R Kohn; J Flood; D Ganem
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

6.  Herpesvirus-like DNA sequences and Kaposi's sarcoma: relationship with epidemiology, clinical spectrum, and histologic features.

Authors:  J C Noel; P Hermans; J Andre; I Fayt; T h Simonart; A Verhest; J Haot; A Burny
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

7.  Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

Authors:  E T Lennette; D J Blackbourn; J A Levy
Journal:  Lancet       Date:  1996-09-28       Impact factor: 79.321

8.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

9.  Disseminated Kaposi's sarcoma in homosexual men.

Authors:  A E Friedman-Kien; L J Laubenstein; P Rubinstein; E Buimovici-Klein; M Marmor; R Stahl; I Spigland; K S Kim; S Zolla-Pazner
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

10.  Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

Authors:  V Beral; T A Peterman; R L Berkelman; H W Jaffe
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.